Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
Anthem coverage decision adds over 45 million covered lives for the Eversense E3 CGM System
Anthem (now Elevance Health) is the second largest health insurance company in the
“Anthem is dedicated to delivering better care to its members and improving the health of the communities it serves. We are excited for Anthem members to have the ability to effectively manage their diabetes through the only long-term implantable CGM system available,” said
Patients who are interested in getting started with Eversense now can sign up at www.eversensediabetes.com/get-started-today. Physicians, nurse practitioners and physician assistants who are interested in offering the Eversense CGM System can sign up at https://www.ascensiadiabetes.com/eversense/become-a-provider/. Alternatively, contact 844-SENSE4U (844-736-7348) to learn more about the first and only long-term implantable CGM system.
About Eversense
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 years and older with diabetes for up to 6 months. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a trained and certified health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://www.ascensiadiabetes.com/eversense/safety-info/.
About
Forward Looking Statements
Any statements in this press release about future expectations, plans and prospects for
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20220803005317r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005317/en/
Senseonics Investor Contact
Investor Relations
415-937-5406
[email protected]
Source:
When should you tap a retirement account to pay off credit card debt?
Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News